Back to results

Massachusetts Institute of Technology

New protein engineering approaches for potentiating and studying antibody-based EGFR antagonism

Abstract

dc:description.abstract

A variety of cancers are marked by the over-expression and over-activity of the EGF receptor (EGFR), rendering this protein an attractive therapeutic target. Anti-EGFR therapeutics are a mainstay of clinical practice for the treatment of colorectal, lung and head and neck cancers but efficacy is limited and response rates low. Opportunities for improving EGFR antagonism include higher potency inhibition of ligand binding, inducing receptor downregulation, or creating synergistic therapeutic combinations. The Wittrup lab has previously made significant advances in EGFR antagonism by demonstrating the therapeutic potential of inducing receptor downregulation through multi-epitopic targeting. The lab has also pioneered the use of a novel protein scaffold, called Sso7d, for yeast surface display-based libraries and selections. In the first part of this work I show that a combination of traditional yeast display techniques with simple but novel in silico approaches can be applied to derive a panel of Sso7d binders against EGFR with diverse paratopes. I demonstrate the superior EGFR inhibition of antibody-Sso7d fusions in vitro, and discuss the lessons learned from applying these proteins in vivo. In the second part of this work I use a structure-guided yeast display approach to create a novel research tool, a minimally modified verstion of cetuximab called "mCetux", which essentially enables in vivo experiments of cetuximab. I apply this antibody tool in vitro and in vivo in a new and highly relevant model system for colorectal cancer and subsequently discuss future opportunities for its use.

Degree

thesis:*
Name thesis:degree_name
Doctoral
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Biological Engineering
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tisdale, Alison Wedekind.
Advisor dc:contributor.advisor
  • K. Dane Wittrup.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1721.1/122521
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/122521

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Tisdale, Alison Wedekind.. New protein engineering approaches for potentiating and studying antibody-based EGFR antagonism. Massachusetts Institute of Technology, 2019. https://hdl.handle.net/1721.1/122521